Is Trelagliptin harmful to the body with long-term use?
Trelagliptin (Trelagliptin) is a new type of oral hypoglycemic drug that belongs to the DPP-4 (dual specificity protease 4) inhibitor class. It inhibits the activity of DPP-4 enzyme and prolongs the action time of insulin, thus helping to maintain blood sugar within the normal range. As a drug for the treatment of type 2 diabetes, trotagliptin has been approved and widely used in many countries.
The scientific community has already conducted certain research and conclusions on whether long-term use of troagliptin is harmful to the body. First of all, the safety of trolagliptin in clinical application has been verified by multiple clinical trials, and no obvious long-term toxic and side effects have been found during long-term use. Most patients maintain good glycemic control while using this drug and it is well tolerated.
However, like other antidiabetic drugs, long-term use of trolagliptin needs to be monitored by a doctor. Generally speaking, it will not directly cause serious damage to the liver or kidneys, but for patients with renal insufficiency, the drug dosage needs to be adjusted appropriately. If patients taking trolagliptin have underlying diseases of the liver or kidneys, their related functions should be monitored regularly under the guidance of a doctor.
In addition, patients taking trotagliptin long-term may face the risks associated with all antidiabetic drugs, such as hypoglycemia, weight gain and other problems. Although DPP-4 inhibitors generally do not cause hypoglycemia, the risk of hypoglycemia remains if used in combination with other antidiabetic drugs (such as sulfonylureas). Therefore, during long-term use, a comprehensive assessment of the patient's overall health and blood sugar levels is required.
Overall, as a long-term treatment of type 2 diabetes, trolagliptin is relatively safe, but it still requires dose adjustment and regular monitoring based on individual differences among patients. As long as it is used rationally and under the guidance of a doctor, most patients can benefit from it without serious side effects.
Reference materials:https://en.wikipedia.org/wiki/Trelagliptin
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)